Find clinical trials for Diabetes in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near New Haven, CT, USA:
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
New Haven, Connecticut, United States and 22 other locations
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...
Bridgeport, Connecticut, United States and 43 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
New Haven, Connecticut, United States and 9 other locations
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Smithtown, New York, United States and 35 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...
New Haven, Connecticut, United States and 62 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Bridgeport, Connecticut, United States and 88 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Waterbury, Massachusetts, United States of America and 58 other locations
The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revol...
New Haven, Connecticut, United States
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
New Haven, Connecticut, United States and 37 other locations
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
New Haven, Connecticut, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal